Zurich to buy AIG travel insurance business for US$600m
June 26 2024 by InsuranceAsia News-
Japanese watchdog fines non-life insurers US$13m for price fixing
- November 1
The report highlighted the summary of violations of antitrust rules by Mitsui Sumitomo, Sompo Japan , Aioi Nissay Dowa and Tokio Marine & Nichido Fire.
-
Sompo, Bigmotor to investigate past claims frauds to compensate customers
- October 31
Bigmotor has changed its name to BALM following the scandal and is planning to announce a concrete recovery strategy for customers next month.
-
Pacific rates drop 6% in Q3 driven by declines in finpro, cyber and property lines: Marsh
- October 25
Finpro premiums was down 14%, while cyber cover saw a 11% disclose and property declined 6% as increased competition and capacity weighed on ratings.
-
Asian insurance market faces turbulence amid nat cats, economic shifts: WTW
- October 24
The Pacific market is experiencing more favourable conditions, with reductions in pricing for various sectors, including construction and liability.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | The hunt for diversification and performance revitalizes appetite for Asian currency bonds
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.